Dark Circles: Types, Causes, Treatments and How to Know What Each Type Needs

This marked discrepancy between personal vitality and facial expression stems directly from the complex anatomical architecture of the periocular region. Dark circles —referred to in dermatology as idiopathic cutaneous hyperchromia of the orbital region or tear trough depression— do not represent a single clinical entity, but a diverse manifestation of distinct tissue factors.

The most widespread error is treating dark circles as a uniform condition with an identical solution for every individual. Clinically, there is neither a single underlying cause nor a universal treatment. Dark circles may result from excess melanin deposition, microvascular visibility through exceptionally thin skin, shadows cast by the orbital rim, tear trough volume loss, herniation of fat pads, or tissue laxity. In many patients, several factors coexist.

For this reason, the guiding premise is clear: not all dark circles are treated the same. Achieving natural, balanced results requires determining which component predominates before any clinical intervention is considered.

From an anatomical perspective, the infraorbital region is a transitional zone of delicate biomechanical balance. It extends from the lower eyelid margin down to the inferior orbital rim and its intersection with the cheek (lid-cheek junction).

To understand why this area reflects variations in pigmentation and contour so prominently, it is necessary to examine its unique tissue characteristics:

• The thinnest skin of the human body: The lower eyelid skin measures merely 0.3 to 0.5 mm in thickness, one-third the thickness of the rest of the facial skin.
• Absence of superficial adipose cushion: In the preseptal segment, there is virtually no superficial subcutaneous fat to act as an optical buffer between dermis and deeper structures.
• Proximity of the orbicularis muscle: The orbicularis oculi muscle (musculus orbicularis oculi), presenting a deep reddish-purple hue, lies directly beneath the delicate cutaneous layer.
• Extensive microcirculation and delicate lymphatic drainage: The region harbors a dense vascular network whose venous and lymphatic return is inherently slow, predisposing to fluid retention and blood stasis.
• Inextensible ligamentous attachments: The tear trough ligament and orbicularis retaining ligament (ORL) anchor soft tissues securely to the periosteum, defining fixed anatomical depressions.

Any alteration in epidermal pigment, microcirculatory flow, or underlying structural support immediately manifests upon the facial surface.

The emergence and progressive prominence of dark circles stems from the interaction of several anatomical and physiological mechanisms:

• Bony morphology and genetics: A wide orbital aperture or a negative orbital vector (where the globe protrudes anteriorly relative to the lower orbital rim) create congenital hollows and shadows from early adulthood.
• Melanin deposition: Excessive melanin accumulation confers a brown or tan hue, whether hereditary (common in intermediate to darker phototypes) or post-inflammatory.
• Vascular congestion: Sluggish venous return leads to accumulation of deoxygenated hemoglobin, yielding a bluish or purplish tint visible through translucent skin.
• Constitutional dermal thinning: Loss of collagen reduces dermal opacity, increasing the visibility of the underlying dark orbicularis muscle and capillary plexus.
• Shadows from facial contours: Under overhead lighting, the orbital rim projects distinct shadows across the infraorbital hollow without requiring excess pigment.
• Bone resorption and deep fat atrophy: Volume loss within deep fat compartments, particularly the suborbicularis oculi fat (SOOF), deepens the groove between eyelid and cheek.
• Tissue laxity and septal attenuation: Weakening of retaining ligaments produces fine skin crepiness and permits the forward herniation of orbital fat pads.
• Chronic inflammatory conditions: Allergic rhinitis induces congestion within periorbital venous plexuses (allergic shiners), while rubbing provokes post-inflammatory hyperpigmentation.

International medical literature classifies dark circles into four primary clinical categories, alongside their combined presentations:

Characterized by a homogenous brown or tan discoloration across the lower eyelid from excess melanin deposition in the epidermis or papillary dermis. Frequent in individuals with genetic predisposition or darker phototypes. Clinically, when gentle manual traction is applied to the eyelid skin, the brown color moves with the skin and remains unchanged in tone.

Present as a bluish or purplish discoloration in the medial third of the lower eyelid from a superficial, congested microvascular bed beneath thin dermal tissue. Fatigue temporarily exacerbates their visibility. Upon skin stretching or light pressure, the purplish hue often dissipates momentarily as blood clears the capillary bed.

In this category, the skin exhibits no intrinsic pigmentation or vascular abnormality. The perceived darkness is purely an optical shadow cast by facial bony contours, a hollow tear trough, or inadequate cheek projection. Under direct frontal lighting, the dark appearance markedly diminishes.

Known clinically as the tear trough hollow, this manifests as a deep groove extending diagonally from the inner canthus down toward the mid-cheek. It arises from firm ligamentous tethering coupled with atrophy of deep cheek fat pads, disrupting the smooth lid-cheek junction.

Occur when intraorbital fat cushions protrude anteriorly due to attenuation of the orbital septum. Unlike hollow dark circles, under-eye bags represent a positive protrusion that casts a sharp shadow along its lower margin, requiring meticulous diagnostic differentiation.

Represent a very frequent presentation in daily clinical practice. A patient frequently presents with thin skin displaying vascular transparency, mild superficial melanin deposition, and an anatomical hollow from deep volume deficiency. Attempting to address this with a single technique is clinically ineffective.

The following table summarizes the defining clinical characteristics of each dark circle type, their underlying biological component, and the general medical strategies evaluated in practice:

Clinical note: This classification is intended for educational purposes and does not replace an in-person medical evaluation by a qualified physician.

Determining the exact nature of dark circles is impossible through a standard digital selfie. Ambient lighting and angles continuously distort shadows, hues, and depth perception.

During a medical evaluation in Benalmadena, the differential diagnosis is conducted through systematic clinical assessments:

• Standardized frontal and tangential lighting: Distinguishes whether darkness is intrinsic to cutaneous tissue or an optical shadow cast by bone.
• Gentle skin traction test (pinch test): Checks whether pigment moves cohesively with epidermis (confirming melanin) or whether hue lightens as skin is lifted from the underlying muscle.
• Assessment of the lid-cheek junction: Evaluates the continuous contour between eyelid and cheek to stage the depth of the tear trough.
• Orbital vector analysis: Evaluates the relationship between the anterior corneal plane and infraorbital rim to predict structural stability.
• Snap-back test and malar edema screening: Examines skin elasticity and lymphatic drainage efficiency, ruling out lymphatic insufficiency that would advise against injectables.

Patients should avoid relying on self-diagnosis; expert clinical guidance is essential.

Biological aging exerts a profound influence on periocular aesthetics, though not all dark circles are age-related. Many young adults live with hollow tear troughs or vascular discoloration from their teenage years due to inherited bone structure.

Nonetheless, biological aging steadily alters periocular tissues:

• Progressive dermal thinning: Synthesis of collagen and elastin steadily declines, reducing dermal density and amplifying vascular transparency. To explore these mechanisms further, consult our clinical guide on facial skin laxity and firmness.
• Deflation of deep facial fat compartments: Deep fat pads supporting the cheek and midface lose volume and descend, exposing the rigid bony orbital rim.
• Orbital bone remodeling: Over decades, the bony orbit expands inferolaterally, decreasing structural support beneath the lower eyelid.
• Cumulative photodamage: Chronic UV exposure exacerbates localized hyperpigmentation in delicate infraorbital skin.

The cumulative result is that a mild shadow visible in a patient's twenties can evolve into a deep tear trough hollow with noticeable skin laxity by their forties.

The widespread belief that extra hours of sleep can cure dark circles is one of the most persistent aesthetic myths.

• What quality sleep truly does: Restful sleep promotes systemic cellular repair, fluid balance, and healthy vascular tone. Chronic sleep deprivation induces compensatory venous engorgement and fluid pooling, leaving the skin paler and vessels more congested, temporarily worsening vascular dark circles.
• What quality sleep CANNOT do: Sleep cannot alter genetically determined melanin distribution, forward-project a cheekbone with lower bony support, rebuild lost volume within the tear trough, or tighten an attenuated orbital septum holding back herniated fat pads.

Restful sleep is an indispensable pillar of dermatological health, but expecting it to resolve anatomical depressions, genetic pigment, or structural fat herniation is clinically unfounded.

The cosmetic industry markets numerous formulations for the under-eye area. Understanding what active ingredients can achieve and what their objective limitations are is essential to setting realistic expectations.

Certain topical agents have demonstrated clinical utility in conditioning periocular skin:

• Caffeine and vasoactive botanical extracts: Temporarily encourage microvascular constriction and lymphatic drainage, offering mild relief for congested vascular dark circles.
• Pure Vitamin C and niacinamide: Potent antioxidants that modulate tyrosinase activity and reinforce epidermal barrier function, brightening superficial tone.
• Carefully formulated retinoids: Promote cellular renewal and stimulate dermal collagen synthesis over months of use, reducing skin translucency.
• Daily broad-spectrum sunscreen: The single most critical topical product to prevent ultraviolet-induced periorbital hyperpigmentation.

It is essential to distinguish the different components involved in dark circles: cosmetic products can help improve hydration, barrier function, and superficial texture in cases of thin or mildly pigmented skin. However, no topical cream can restore volume to an atrophic fat compartment, lift a sunken tear trough ligament, alter structural bony shadows, or remove herniated orbital fat. Confusing epidermal conditioning with structural volume restoration or surgical correction remains a major source of patient disappointment.

In advanced aesthetic medicine, the therapeutic options must be tailored strictly to the underlying diagnosis of each patient:

• Medical skincare optimization and photoprotection: Fundamental first step for protecting epidermal health and preventing ongoing pigment accumulation.
• Medical chemical peels: Formulated specifically for the delicate periocular zone with agents such as tranexamic or kojic acid to modulate melanin synthesis in pigmented dark circles.
• Dermal biostimulation and periocular mesotherapy: Targeted micro-deposits of non-crosslinked hyaluronic acid, biomimetic peptides, or amino acids designed to redensify thin dermis and enhance hydration.
• Neuromodulators: In patients exhibiting dynamic wrinkles in the lateral canthal area or orbicularis muscle hyperactivity, neuromodulators help soften muscular pulling around the eyes while preserving natural expression.
• Hyaluronic acid dermal fillers: Can be evaluated in select patients when an anatomical tear trough hollow or structural volume deficiency is present.
• Surgical blepharoplasty: When specific anatomical changes predominate, such as fat herniation or excess skin, a surgical option may be evaluated following appropriate medical assessment.

No medical treatment is universally superior; clinical appropriateness is dictated solely by individual anatomy and personalized clinical evaluation.

Hyaluronic acid dermal filler can be evaluated in select patients presenting with tear trough depression, following individual medical evaluation. For a detailed overview of this biomaterial, explore our complete scientific guide to hyaluronic acid.

It may be considered when an anatomical hollow or tear trough depression is present, accompanied by good skin elasticity, healthy lymphatic drainage, and absence of prominent orbital fat pads. The clinical objective is to soften the eyelid-cheek transition to diminish the shadow created by the depression, respecting natural periocular dynamics and individual anatomy.

• In pure pigmented dark circles: Hyaluronic acid does not diminish melanin pigmentation. Placing filler beneath flat, pigmented skin does not alter discoloration and can distort surface contour.
• In the presence of prominent under-eye bags: Infiltrating filler adjacent to herniated fat pads accentuates local fullness and distorts eyelid proportions.
• In patients prone to malar edema: Because hyaluronic acid is hydrophilic and binds water, its use in individuals with compromised lymphatic drainage can promote persistent puffiness.
• In marked skin laxity: Without adequate tissue elasticity, the product cannot integrate smoothly. In such situations, medical recommendations should be redirected toward other modalities or surgical evaluation.

The vascular complexity and thin cutaneous coverage of the periocular region require rigorous patient selection and experienced medical judgment.

In conscientious clinical practice, recognizing when to withhold direct tear trough treatment is vital. Direct filler placement is ill-advised when the depression is secondary to lost cheek support.

In select patients, it may be necessary to evaluate midface support and transition before deciding how to approach the infraorbital area. Addressing the tear trough in isolation when cheek support is reduced may yield suboptimal harmony; the approach must therefore be tailored to individual anatomy.

Similarly, in the presence of active dermatitis, malar festoons, or severe orbital septal laxity, direct tear trough injections should be postponed or avoided.

Conflating dark circles with under-eye bags is a common error that leads to improper treatment choices:

• Dark circles represent issues of coloration (brown, blue, purple) or negative relief (hollows, bony depression, shadows).
• Under-eye bags represent a condition of positive volume or protrusion, caused by the forward herniation of intraorbital fat pads through a weakened orbital septum, or chronic lymphatic pooling.

Their therapeutic management is conceptually distinct: while an anatomical hollow may benefit from selective volume restoration in indicated candidates, a bulging fat pad must never be augmented with fillers, requiring surgical evaluation or medical lymphatic care depending on the presentation.

In aesthetic medicine, diagnostic transparency is the cornerstone of patient satisfaction. Periocular medical procedures are designed to:

• Soften abrupt transitional steps across the facial profile.
• Diminish the depth of hollows and the harshness of cast shadows.
• Enhance skin quality, hydration, and superficial radiance.
• Harmonize overall eye expression without altering identity.

Conversely, medical treatments DO NOT guarantee the permanent erasure of all darkness, will not remove natural dynamic smile lines, cannot stop intrinsic biological aging, and cannot replace surgery when severe fat herniation is present.

Every medical procedure carries potential risks and side effects that must be communicated clearly and objectively.

Regarding periocular hyaluronic acid treatments, risks include:

• Mild, common side effects: Transient swelling, redness, mild localized tenderness, and small bruises, which typically resolve within days.
• Technical or product-related complications: Tyndall effect: A bluish or grayish tint visible when hyaluronic acid is placed too superficially, causing optical light scattering. Contour irregularities and nodules: Palpable reliefs or asymmetries resulting from overcorrection or product displacement. Persistent lymphatic edema:* Prolonged puffiness along the infraorbital margin in patients with compromised drainage.
• Rare but severe complications: Medical literature documents risks of vascular compromise resulting from unintended intravascular injection or severe external compression, which can lead to localized skin necrosis or, in exceedingly rare cases, visual impairment.

Procedures in this area require thorough medical evaluation and precise knowledge of periocular anatomy. Although severe complications are uncommon, they must be explained clearly prior to any intervention.

• Myth 1: "All dark circles are caused by lack of sleep." Reality: Fatigue temporarily worsens vascular pooling, but the primary cause is often linked to genetic bone structure, skin thickness, and melanin distribution.
• Myth 2: "There is an eye cream that permanently erases dark circles." Reality: Skincare can improve hydration and mildly brighten surface tone, but cannot rebuild sunken bone or reposition bulging orbital fat.
• Myth 3: "If I have a hollow under my eyes, I always need filler." Reality: If skin is severely lax or cheek support is lacking, direct tear trough filler can cause complications. Assessing the midface or considering surgery is often preferable.
• Myth 4: "Under-eye bags and dark circles are the same thing." Reality: Dark circles are color changes or hollows (negative relief); bags are bulging fat cushions (positive relief). Their treatments are completely distinct.
• Myth 5: "A single treatment can solve all types of dark circles." Reality: Because many patients present with mixed dark circles, a staged combination of different approaches may be considered depending on clinical evaluation.

A formal medical consultation is recommended in the following circumstances:

• When a perpetually tired expression persists despite healthy lifestyle habits and causes personal aesthetic concern.
• If a deepening tear trough hollow creates a noticeable step that ages the facial expression.
• If marked asymmetry, sudden darkening, or chronic puffiness develops around the eyes.
• Before investing in costly skincare regimens or invasive treatments without an accurate clinical diagnosis.

At our medical clinic in Benalmadena, every consultation begins with an honest, comprehensive facial assessment, identifying which treatments are safe and scientifically grounded, and which should be avoided.

• Vrcek I, Ozgur O, Nakra T. Infraorbital Dark Circles: A Review of the Pathogenesis, Evaluation and Treatment. J Cutan Aesthet Surg. 2016;9(2):65-72. doi:10.4103/0974-2077.184046. PMID: 27398005.
• Huang YL, Chang SL, Ma L, Lee MC, Hu S. Clinical analysis and classification of dark eye circle. Int J Dermatol. 2014;53(2):164-170. doi:10.1111/ijd.12140. PMID: 23879616.
• Ivanic M, et al. Treatments of Periorbital Hyperpigmentation: A Systematic Review. Dermatol Surg. 2021;47(1):90-95. PMID: 32740208.
• Friedmann DP, Goldman MP. Periorbital Hyperpigmentation: A Comprehensive Review. J Clin Aesthet Dermatol. 2015;8(10):25-37. PMID: 26962392.
• Lim A, et al. Periorbital Discolouration Diagnosis and Treatment: Evidence-Based Review. J Cosmet Laser Ther. 2021;23(1-2):1-14. doi:10.1080/14764172.2021.1899238. PMID: 34078228.
• Mustak H, et al. Complications associated with infraorbital filler injection. J Cosmet Laser Ther. 2021;23(3-4):67-72. doi:10.1080/14764172.2021.1909067. PMID: 33794721.
• Viana GAP, et al. Infraorbital Hyaluronic Acid Filler: Common Aesthetic Side Effects With Treatment and Prevention Options. Aesthet Surg J Open Forum. 2022;4:ojac001. doi:10.1093/asjof/ojac001. PMID: 35386936.
• Yan C, et al. Safety of infraorbital hyaluronic acid injections: Outcomes of a meta-analysis on prospective clinical trials. Aesthet Surg J. 2023;43(11):1321-1331. PMID: 37424173.
• Robinson S, et al. What's New With Under Eye Treatment: A Multispecialty Systematic Review of Recent Under Eye Treatments. Dermatol Surg. 2026. doi:10.1097/DSS.0000000000004964.
• Lower Eyelid Dark Circles (Tear Trough and Lid-Cheek Junction): A Stepwise Assessment Framework. Aesthet Surg J. 2024;44(8):843-855. doi:10.1093/asj/sjae058. PMID: 38489829.
• Sharad J. Dermal Fillers for Tear Trough Rejuvenation: A Systematic Review. Facial Plast Surg. 2022;38(3):284-293. PMID: 34192769.
• Hirmand H, et al. Tear Trough Filler Techniques Utilizing Hyaluronic Acid: A Systematic Review. Plast Reconstr Surg. 2022;149(4):861e-871e. doi:10.1097/PRS.0000000000008990. PMID: 35259144.